D. E. Shaw & Co., Inc. Charles River Laboratories International, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $2.81 Million - $3.59 Million	8,000 Added 123.08%	14,500 $5.46 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $2.42 Million - $2.98 Million	6,500 New	6,500 $2.68 Million

721

52M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.